Landscapes / Companies
EMD Serono Research & Development Institute, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
2 in Phase 3
Drugs
10
in active trials · 26 in all
Trials
13 active
66 since 2021
Drugs10
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Programmed death ligand-1 blocker |
Approved | 24 Nov 2026soonPhase 3 trial completes | |||
| How it works | Releases a brake on the immune system (PD-1 or PD-L1) so it attacks cancer cells | ||||
| Next date | 24 Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Solid Tumors, Locally Advanced or Metastatic Urothelial Carcinoma | ||||
| Open drug page | |||||
Kinase inhibitor |
Merck KGaA, Darmstadt, Germany |
Approved | — | ||
| How it works | Blocks a kinase | ||||
| Also tested for | Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV | ||||
| Open drug page | |||||
Artificial immunoglobulin |
Phase 3 | 23 Dec 2027Phase 1/2 trial completes | |||
| How it works | An antibody | ||||
| Next date | 23 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Colorectal Cancer, Solid Tumors and 5 more | ||||
| Open drug page | |||||
— |
Phase 3 | 12 Aug 2028Phase 2 trial completes | |||
| Next date | 12 Aug 2028 · Phase 2 trial completes | ||||
| Also tested for | Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE) and 3 more | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Locally Advanced or Metastatic Urothelial Carcinoma | ||||
| Open drug page | |||||
— |
Phase 1 | 22 Feb 2027Phase 1 trial completes | |||
| Next date | 22 Feb 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 22 Feb 2027Phase 1 trial completes | |||
| Next date | 22 Feb 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 16 Apr 2027Phase 1 trial completes | |||
| Next date | 16 Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 28 Sep 2028Phase 1 trial completes | |||
| Next date | 28 Sep 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 23 Feb 2029Phase 1 trial completes | |||
| Next date | 23 Feb 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 16 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021